Calendrier des promotions ImmuCell Corporation
Calendrier avancé
Graphique simple
À propos de l'entreprise ImmuCell Corporation
ImmuCell Corporation, an animal health company, develops, manufactures, and markets products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. It offers First Defense, an orally delivered scours preventive product for newborn dairy and beef calves; and Tri-Shield First Defense, a passive antibody product for the treatment of E. coli, coronavirus, and rotavirus. The company also provides California Mastitis Test that is used to detect somatic cell counts in milk, as well as to determine, which quarter of the udder is mastitic; and Dual-Force First Defense, including a whey protein concentrate for the nutritional and feed supplement markets. In addition, it is involved in developing Re-Tain, a Nisin-based intramammary treatment of subclinical mastitis in lactating dairy cows. It sells its products through animal health distributors. ImmuCell Corporation was incorporated in 1982 and is headquartered in Portland, Maine.Paramètres de base
IPO date
1987-04-30
ISIN
US4525253062
Industry
Biotechnology
Sector
Health Care
Валюта
usd
Валюта отчета
usd
Сайт
Grade
Sous-estimation
Nom | Signification | Grade |
P/S | 1.49 | 9 |
P/BV | 1.43 | 9 |
P/E | 0 | 0 |
Efficacité
Nom | Signification | Grade |
ROA | -4.85 | 0 |
ROE | -8.21 | 0 |
ROIC | 0 | 0 |
Dividendes
Nom | Signification | Grade |
Rendement en dividendes | 0 | 0 |
DSI | 0 | 0 |
Croissance moyenne du dividende | 0 | 0 |
Devoir
Nom | Signification | Grade |
Debt/EBITDA | 14.46 | 0 |
Debt/Ratio | 0.3348 | 10 |
Debt/Equity | 0.6389 | 9 |
Impulsion de croissance
Nom | Signification | Grade |
Rentabilité Revenue, % | 73.16 | 8 |
Rentabilité Ebitda, % | -174.6 | 0 |
Rentabilité EPS, % | 86.36 | 9 |
paper.price.prices
Prix | Common.min. | Common.max. | Changement | paper.changes_in_industry | paper.changes_in_index | |
common.calendar.number_days.1 | 6.49 $ | 0 $ | 0 $ | 0 % | 0 % | 0 % |
common.calendar.number_days.7d | 6.29 $ | 0 $ | 0 $ | 3.18 % | 0 % | 0 % |
common.calendar.number_days.30d | 6.52 $ | 6.26 $ | 6.75 $ | -0.46 % | 0 % | 0 % |
common.calendar.number_days.90d | 5.41 $ | 4.81 $ | 6.87 $ | 19.96 % | 0 % | 0 % |
common.calendar.number_days.180d | 5.11 $ | 4.78 $ | 6.87 $ | 27.01 % | 0 % | 0 % |
common.calendar.number_days.1y | 3.8 $ | 3.53 $ | 6.87 $ | 70.79 % | 0 % | 0 % |
common.calendar.number_days.3y | 7.4 $ | 3.53 $ | 9.1 $ | -12.3 % | 0 % | 0 % |
common.calendar.number_days.5y | 5.61 $ | 3.53 $ | 11.88 $ | 15.69 % | 0 % | 0 % |
common.calendar.number_days.10y | 3.53 $ | 3.53 $ | 11.88 $ | 183.85 % | 0 % | 0 % |
common.calendar.number_days.ytd | 5.3 $ | 4.78 $ | 6.87 $ | 22.45 % | 0 % | 0 % |
Principaux propriétaires
Entreprises similaires
P/E & P/BV
Gestion d'entreprise
Superviseur | Titre d'emploi | Paiement | Année de naissance |
Mr. Michael F. Brigham | President, CEO, Principal Financial Officer, Treasurer, Secretary & Director | 395.24k | 1961 (64 année) |
Ms. Bobbi Jo Brockmann | VP of Sales & Marketing and Director | 323.52k | 1977 (48 années) |
Mr. A. Gustavo Scaffa | Senior Director of Quality | N/A | |
John W. Zinckgraf | Director of Product Development | N/A | |
Ms. Elizabeth L. Williams | Vice President of Manufacturing Operations | 312.07k | 1956 (69 années) |
Ms. Elizabeth S. Toothaker | Director of Finance & Administration and Controller | N/A |
Informations sur l'entreprise
Adresse: United States, Portland. ME, 56 Evergreen Drive - Ouvrir dans google maps, Ouvrir les cartes yandex
Site web: https://immucell.com
Site web: https://immucell.com